Synmosa Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.3%.

Top 14 shareholders own 19.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.76%	Formosa Time Pharmaceutical Co., Ltd.	25,813,430	NT$995.1m	0%	no data
4.69%	Zhihui Lin	17,919,646	NT$690.8m	0%	no data
3.39%	The Vanguard Group, Inc.	12,941,022	NT$498.9m	-1.18%	no data
1.2%	BlackRock, Inc.	4,584,100	NT$176.7m	5.87%	no data
1.01%	You-Peng Zhang	3,845,661	NT$148.3m	0%	no data
0.96%	Li-Wen Huang	3,672,093	NT$141.6m	2.72%	no data
0.56%	Dimensional Fund Advisors LP	2,134,553	NT$82.3m	51.7%	no data
0.36%	Jia-Xin Zhang	1,380,301	NT$53.2m	0%	no data
0.11%	State Street Global Advisors, Inc.	402,962	NT$15.5m	0%	no data
0.07%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	265,841	NT$10.2m	-2.92%	no data
0.068%	Allianz Global Investors U.S. LLC	260,568	NT$10.0m	-6.97%	no data
0.023%	Eaton Vance Management	88,976	NT$3.4m	0%	no data
0.012%	HSBC Global Asset Management (UK) Limited	47,600	NT$1.8m	143%	no data
0.0043%	Northern Trust Global Investments	16,272	NT$627.4k	0%	no data